Exelixis Inc. (EXEL)
EXEL trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$59.51
-0.52% on the day
Market cap
$14.7B
Large cap
Revenue · 2025
$2.3B
+7.0% on 2024
Net income · 2025
$782.6M
33.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | EXEL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2000 |
| SEC CIK | 0000939767 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.3B |
| Net income | $782.6M |
| Operating income | $872.2M |
| Net margin | 33.7% |
| Operating margin | 37.6% |
| Revenue growth | +7.0% |
| Cash | $482.5M |
| Total assets | $2.8B |
| P/E (computed) | 18.8× |
| P/S (computed) | 6.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K | 2026-02-10 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-09-11 |
| Latest proxy | DEFA14A | 2026-04-17 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +4.4% |
| 1 month | +7.2% |
| 3 months | +9.6% |
| Year to date | +39.2% |
| 1 year | +58.7% |
| From 52-week high | 0.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc. | $135.13 | -4.41% | $13.7B |
| HALO | Halozyme Therapeutics Inc. | $109.62 | -1.31% | $12.4B |
| TECH | Bio-Techne Corp | $72.48 | -0.11% | $11.4B |
| PCVX | Vaxcyte Inc. | $66.80 | -5.45% | $10.5B |
| IBRX | ImmunityBio Inc. | $9.80 | -3.16% | $10.4B |
| TWST | Twist Bioscience Corporation | $151.33 | -0.35% | $10.0B |
| BNTX | BioNTech SE American Depositary Share | $89.01 | -7.13% | $22.4B |
| KRYS | Krystal Biotech Inc. | $321.16 | -3.29% | $9.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier